高级检索
当前位置: 首页 > 详情页

A worldwide bibliometric analysis of triptolide research from 1997 to 2021

| 认领 | 导出 |

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE ◇ 预警期刊

单位: [1]Xiangya Hosp, Dept Orthoped, Cent South Univ, Changsha, Hunan, Peoples R China [2]Cent South Univ, Xiangya Sch Med, Changsha, Hunan, Peoples R China [3]Natl Univ Mongolia, Sch Arts & Sci, Ulaanbaatar 14201, Mongolia [4]China Japan Friendship Hosp, Dept Orthoped, Beijing, Peoples R China
出处:
ISSN:

关键词: Bibliometric analysis triptolide VOSviewer CiteSpace Rstudio

摘要:
Objectives: In recent years, triptolide has received much attention due to its wide range of pharmacological activities. However, no bibliometric studies have been published on triptolide. This study conducted a bibliometric study to provide scientific and insightful information for further research. Methods: This study performed a bibliometric study of articles published in the Web of Science database from 1997 to 2021. Based on the keywords used in relation to the title of the article containing the word triptolide, 970 publications were searched for further analysis. We used Microsoft Excel for frequency analysis, VOSviewer and CiteSpace for data visualization, and Rstudio for citation metrics and analysis. Results: After analysis, standard bibliometric indicators such as the growth of publications, prolific authors and coauthorship, country distributions, preferred journals, most influential institutions and top cited documents were presented in this study. Conclusions: According to our findings, the number of triptolide-related publications has been increasing since 2009. China was the largest contributor to triptolide research, followed by the USA. Biomedicine & Pharmacotherapy was the leading journal related to triptolide research. The most productive authors were Zhang LY (China Pharmaceut Univ) and Jiang ZZ (China Pharmaceut Univ). China Pharmaceutical University was the most influential institution in the field of triptolide research. Our findings suggest that the effective use of triptolide in cancer therapy as well as overcoming its multiorgan toxicity to promote its widespread clinical applications are expected to be hot research topics in the future.

基金:
语种:
WOS:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 3 区 医学
小类 | 4 区 肿瘤学 4 区 医学:研究与实验
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 肿瘤学
JCR分区:
出版当年[2020]版:
Q2 MEDICINE, RESEARCH & EXPERIMENTAL Q3 ONCOLOGY
最新[2023]版:
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Q4 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2020版] 出版当年五年平均[2016-2020] 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者单位: [1]Xiangya Hosp, Dept Orthoped, Cent South Univ, Changsha, Hunan, Peoples R China
通讯作者:
通讯机构: [1]Xiangya Hosp, Dept Orthoped, Cent South Univ, Changsha, Hunan, Peoples R China [4]China Japan Friendship Hosp, Dept Orthoped, Beijing, Peoples R China [*1]Cent South Univ, Xiangya Hosp, Dept Orthoped, 87 Xiangya Rd, Changsha 410000, Peoples R China [*2]China Japan Friendship Hosp, Dept Orthoped, Beijing 100029, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)